Yüklüyor......
Initial Testing (Stage 1) of Ganetespib, an Hsp90 Inhibitor, by the Pediatric Preclinical Testing Program
Ganetespib, an Hsp90 inhibitor, was tested against the PPTP in vitro cell line panel and selected xenografts in vivo, including JAK2- and BRAF-mutated models. Ganetespib demonstrated potent in vitro cytotoxic activity (median rIC(50) 8.8 nM, range 4.4–27.1 nM). In vivo, ganetespib induced significan...
Kaydedildi:
| Yayımlandı: | Pediatr Blood Cancer |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4225043/ https://ncbi.nlm.nih.gov/pubmed/23303741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24451 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|